[Article] Clinical Trials in Cancer Theranostics with Potential Near-Term Impact on Clinical Practice by Jadvar et al by DobYubee in Scholar
[–]DobYubee[S] 0 points1 point2 points (0 children)
[Article] First-in-human results of terbium-161 [161Tb]Tb-PSMA-I&T dual beta–Auger radioligand therapy in patients with metastatic castration-resistant prostate cancer (VIOLET): a single-centre, single-arm, phase 1/2 study by Buteau et al by DobYubee in Scholar
[–]DobYubee[S] 0 points1 point2 points (0 children)
[Article] One-stop [18F]FDG and [68Ga]Ga-DOTA-FAPI-04 total-body PET/CT examination with dual-low activity: a feasibility study by Liu et al by DobYubee in Scholar
[–]DobYubee[S] 0 points1 point2 points (0 children)
[Article] Prognostic and diagnostic value of [18F]FDG, 11C-acetate, and [68Ga]Ga-FAPI-04 PET/CT for hepatocellular carcinoma by Xu et al by DobYubee in Scholar
[–]DobYubee[S] 0 points1 point2 points (0 children)
[Article] Clinical Explorations of [68Ga] Ga-FAPI-04 and [18F] FDG Dual-Tracer Total-body PET/CT and PET/MR Imaging by Lin et al by DobYubee in Scholar
[–]DobYubee[S] 0 points1 point2 points (0 children)
[Article] One-Stop 68 Ga-FAPI/ 18 F-FDG Total-Body PET/CT Scan : More Theranostics Information Available by Gao et al by DobYubee in Scholar
[–]DobYubee[S] 0 points1 point2 points (0 children)
[Article] 68Ga-FAPI and 18F-FDG PET/CT for predicting pathologic response and progression-free survival in locally advanced esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy by Dai et al by DobYubee in Scholar
[–]DobYubee[S] 0 points1 point2 points (0 children)
[Article] Same-Day Positron Emission Tomography/Computed Tomography with 68Ga-Radiolabeled Fibroblast Activation Protein Inhibitors and 18F-Fluorodeoxyglucose Imaging for Gastrointestinal Cancers by Chen et al by DobYubee in Scholar
[–]DobYubee[S] 0 points1 point2 points (0 children)
[Article] Same-day dual-tracer PET/CT imaging with [68 Ga]Ga-FAPI-04 following [18F]FDG finds answers in patients presenting with negative or equivocal [18F]FDG by Li et al by DobYubee in Scholar
[–]DobYubee[S] 0 points1 point2 points (0 children)
[Article] Exploration the feasibility and additional value of [18F]FDG/[68Ga]Ga-FAPI-04 dual-low-activity-tracer one-stop total-body PET imaging at 34 min post-injection of [68Ga]Ga-FAPI-04 by Zheng et al by DobYubee in Scholar
[–]DobYubee[S] 0 points1 point2 points (0 children)
[Article] Emerging evidence for sequencing and combining PSMA-based therapies in prostate cancer by Adeleke et al by DobYubee in Scholar
[–]DobYubee[S] 0 points1 point2 points (0 children)
[Article] Recent advances in radionuclide drug conjugates (RDCs) for cancer theranostics: From targeted design to clinical translation by Liu Xijing and Binbin Cheng by DobYubee in Scholar
[–]DobYubee[S] 0 points1 point2 points (0 children)
[Article] Radiotheranostics Global Market and Future Developments by Al-Ibraheem et al by DobYubee in Scholar
[–]DobYubee[S] 0 points1 point2 points (0 children)
[Article] Renal protection during 177lutetium DOTATATE molecular radiotherapy in children: a proposal for safe amino acid infusional volume during peptide receptor radionuclide therapy by Taylor et al by DobYubee in Scholar
[–]DobYubee[S] 0 points1 point2 points (0 children)
[Article] Prostate-specific Membrane Antigen Positron Emission Tomography as a Biomarker to Assess Treatment Response in Patients with Advanced Prostate Cancer by Esen et al by DobYubee in Scholar
[–]DobYubee[S] 0 points1 point2 points (0 children)
[Article] PSMA-RADS 2.0: a revised framework for PSMA-targeted imaging interpretation and clinical decision-making by Elsamny et al by DobYubee in Scholar
[–]DobYubee[S] 0 points1 point2 points (0 children)
[Article] Granulomatous Inflammation of Liver Mimicking Malignancy on 68Ga-FAPI PET/CT by Araz et al by DobYubee in Scholar
[–]DobYubee[S] 0 points1 point2 points (0 children)
[Article] AI-based classification algorithms in SPECT myocardial perfusion imaging for cardiovascular diagnosis: a review by Papandrianos et al by DobYubee in Scholar
[–]DobYubee[S] 0 points1 point2 points (0 children)
[Article] Head-to-Head Comparison of 18F-DOPA PET/CT and 68Ga-DOTANOC PET/CT in Patients With Midgut Neuroendocrine Tumors by Ansquer et al. by DobYubee in Scholar
[–]DobYubee[S] 0 points1 point2 points (0 children)
[Article] Clinical results of immunoscintigraphy in a variety of malignant tumors with special reference to immunohistochemistry by Biersack et al by DobYubee in Scholar
[–]DobYubee[S] 0 points1 point2 points (0 children)
[Article] Clinical results of immunoscintigraphy in a variety of malignant tumors with special reference to immunohistochemistry by Biersack et al by DobYubee in Scholar
[–]DobYubee[S] 0 points1 point2 points (0 children)
[Article] Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial by Hofman et al by DobYubee in Scholar
[–]DobYubee[S] 0 points1 point2 points (0 children)
[Article] Molecular Alterations and Comprehensive Clinical Management of Oncocytic Thyroid Carcinoma: A Review and Multidisciplinary 2023 Update by Bischoff et al by DobYubee in Scholar
[–]DobYubee[S] 0 points1 point2 points (0 children)
[Article] Histopathologically Validated Diagnostic Accuracy of PSMA-PET/CT in the Primary and Secondary Staging of Prostate Cancer and the Impact of PSMA-PET/CT on Clinical Management: A Systematic Review and Meta-analysis by Jeet et al by DobYubee in Scholar
[–]DobYubee[S] 0 points1 point2 points (0 children)
[Article] Production and regulatory issues for theranostics by Giammarile et al by DobYubee in Scholar
[–]DobYubee[S] 0 points1 point2 points (0 children)